2026-09-09T10:11:07.000Z · 24 days ago Nautilus Biotechnology initiated with an Outperform at Leerink
Sep 4, 2026, 8:00 AM EDT · 4 weeks ago Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms
Jul 28, 2026, 8:00 AM EDT · 2 months ago Nautilus Biotechnology Reports Second Quarter 2026 Financial Results
Jul 8, 2026, 8:00 AM EDT · 2 months ago Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026
Apr 28, 2026, 8:00 AM EDT · 5 months ago Nautilus Biotechnology Reports First Quarter 2026 Financial Results
2026-03-18T12:11:28.000Z · 6 months ago Nautilus announces first customer of its Iterative Mapping Early Access Program
Mar 18, 2026, 8:00 AM EDT · 6 months ago Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform
2026-03-02T13:31:20.000Z · 7 months ago Nautilus Biotechnology appoints Faust as Vice President of Sales
2026-02-27T12:36:19.000Z · 7 months ago Nautilus Biotechnology price target raised to $4 from $2.50 at Guggenheim
2026-02-26T13:21:03.000Z · 7 months ago Nautilus Biotechnology reports Q4 EPS (11c) vs (14c) last year
Feb 19, 2026, 4:05 PM EST · 7 months ago Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
2026-01-28T13:18:27.000Z · 8 months ago Nautilus Biotechnology announces research collab with WCM-Q, MJFF
2026-01-08T13:41:42.000Z · 8 months ago Nautilus launches Early Access Program for novel proteomics platform
2025-11-03T13:15:18.000Z · 11 months ago Nautilus announces installation, testing of its external field evaluation unit
Nov 3, 2025, 8:00 AM EST · 11 months ago Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging
2025-10-28T12:05:14.000Z · 11 months ago Nautilus Biotechnology reports Q3 EPS (11c) vs (13c) last year
Aug 27, 2025, 8:00 AM EDT · 1 year ago Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
Jul 31, 2025, 8:00 AM EDT · 1 year ago Nautilus Biotechnology Reports Second Quarter 2025 Financial Results
Jul 15, 2025, 8:00 AM EDT · 1 year ago Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025
2025-02-28T13:17:03.000Z · 1 year ago Nautilus Biotechnology price target lowered to $2.50 from $4 at Guggenheim
Feb 27, 2025, 9:50 AM EST · 1 year ago Nautilus Biotechnology layoffs 16% of workforce, plans release of commercial platform in 2026
2024-12-05T10:15:22.000Z · 1 year ago Nautilus Biotechnology downgraded to Sell from Neutral at Goldman Sachs
Oct 31, 2024, 8:00 AM EDT · 1 year ago Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award
Oct 30, 2024, 8:00 AM EDT · 1 year ago Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
Jul 30, 2024, 8:00 AM EDT · 2 years ago Nautilus Biotechnology Reports Second Quarter 2024 Financial Results
Jul 9, 2024, 8:00 AM EDT · 2 years ago Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024
Apr 30, 2024, 8:00 AM EDT · 2 years ago Nautilus Biotechnology Reports First Quarter 2024 Financial Results
Apr 11, 2024, 8:00 AM EDT · 2 years ago Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
Feb 28, 2024, 8:00 AM EST · 2 years ago Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Feb 22, 2024, 8:00 AM EST · 2 years ago Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference
Feb 7, 2024, 8:00 AM EST · 2 years ago Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
Nov 30, 2023, 8:00 AM EST · 2 years ago Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award
Nov 1, 2023, 8:05 AM EDT · 2 years ago Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development
Oct 31, 2023, 8:05 AM EDT · 2 years ago Nautilus Biotechnology Reports Third Quarter 2023 Financial Results
Oct 11, 2023, 8:05 AM EDT · 2 years ago Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023
Aug 4, 2023, 8:00 AM EDT · 3 years ago Nautilus Biotechnology to Participate in Upcoming August Investor Conferences
Aug 2, 2023, 7:30 AM EDT · 3 years ago Nautilus Biotechnology Reports Second Quarter 2023 Financial Results
Jul 11, 2023, 9:23 AM EDT · 3 years ago Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023
May 24, 2023, 8:05 AM EDT · 3 years ago Nautilus Biotechnology to Participate in Upcoming June Investor Conferences
May 2, 2023, 6:30 AM EDT · 3 years ago Nautilus Biotechnology Reports First Quarter 2023 Financial Results
Apr 18, 2023, 4:05 PM EDT · 3 years ago Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023
Mar 23, 2023, 8:00 AM EDT · 3 years ago Nautilus Biotechnology to Participate in B. Riley Securities' Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference
Feb 23, 2023, 6:05 AM EST · 3 years ago Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results
Feb 21, 2023, 8:00 AM EST · 3 years ago Nautilus Biotechnology to Participate in the 43rd Annual Cowen Health Care Conference
Jan 26, 2023, 8:00 AM EST · 3 years ago Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
Jan 19, 2023, 8:00 AM EST · 3 years ago Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)
Dec 27, 2022, 10:53 AM EST · 3 years ago Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs
Nov 1, 2022, 6:05 AM EDT · 3 years ago Nautilus Biotechnology Reports Third Quarter 2022 Financial Results
Sep 23, 2022, 8:00 AM EDT · 4 years ago Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit
Sep 1, 2022, 8:00 AM EDT · 4 years ago Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board
Aug 30, 2022, 8:00 AM EDT · 4 years ago Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference
Aug 2, 2022, 6:48 AM EDT · 4 years ago Nautilus Biotechnology Reports Second Quarter 2022 Financial Results
Jul 13, 2022, 8:00 AM EDT · 4 years ago Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022
May 3, 2022, 6:00 AM EDT · 4 years ago Nautilus Biotechnology Reports First Quarter 2022 Financial Results
Apr 7, 2022, 8:00 AM EDT · 4 years ago Nautilus Biotechnology to Announce First Quarter 2022 Financial Results on May 3, 2022
Mar 31, 2022, 4:05 PM EDT · 4 years ago Nautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to Board of Directors
Feb 24, 2022, 6:00 AM EST · 4 years ago Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2021 Financial Results
Feb 16, 2022, 4:05 PM EST · 4 years ago Nautilus to Participate in the 42nd Annual Cowen Health Care Conference
Jan 21, 2022, 8:11 PM EST · 4 years ago Jim Cramer considers the investment cases for Nautilus Biotechnology and Cyxtera Technologies